Nature Medicine, 2025
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection

Duff E., Zetterberg H., Heslegrave A. et al.

Frontiers in Oncology, 2025
Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Uffenorde J., Hariri M., Papalanis E. et al.

Science Translational Medicine, 2025
Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection

Chan L., Pinedo K., Stabile M. et al.

Nature Communications, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

Bolsewig K., Willemse E., Sánchez-Juan P. et al.

Journal of Inflammation Research, 2025
CLEC11A-Driven Molecular Mechanisms in Intervertebral Disc Degeneration: A Comprehensive Multi-Omics Study

Jiang N., Wang Q., Hu Z. et al.

Scientific Reports, 2025
Increased FGF-19 levels following explantation in women with breast implant illness

Azahaf S., Spit K., de Blok C. et al.

Heliyon, 2025
Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning

Safi A., Giunti E., Melikechi O. et al.

Atherosclerosis, 2025
Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization

Xu D., Lu J., Yang Y. et al.

Current Issues in Molecular Biology, 2025
The Role of Cytokines and Chemokines as Biomarkers of Disease Activity in Idiopathic Nephrotic Syndrome in Children

Kopač M., Jerin A., Petrera A. et al.

International Journal of Molecular Sciences, 2025
Comparative Assessment of Acute Pulmonary Effects Induced by Heat-Not-Burn Tobacco Aerosol Inhalation in a Murine Model

Kim B., Yang W., Seong Y. et al.

Frontiers in Immunology, 2025
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis

Ozuna H., Bojja D., Partida-Sanchez S. et al.

Journal for ImmunoTherapy of Cancer, 2025
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial

Pakola S., Clubb J., Kudling T. et al.

Scientific Reports, 2025
Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics

Liu Y., Zhang Y., Wan Q.

The FASEB Journal, 2025
Novel inflammatory markers in intracerebral hemorrhage: Results from Olink proteomics analysis

Hu Z., Chen S., Zhang E. et al.

Nature Genetics, 2025
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease

Yoshiji S., Lu T., Butler-Laporte G. et al.

CHEST Critical Care, 2025
Immunomodulation for acute respiratory distress syndrome: insights from proteomics in COVID-19

Rademaker E., Haitsma Mulier J., Drylewicz J. et al.

Pediatric Research, 2025
Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls

Buonsenso D., Cotugno N., Amodio D. et al.

British Journal of Dermatology, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)

Silverberg J., Eichenfield L., Blauvelt A. et al.

European Heart Journal, 2025
Fibroblast growth factor 5: a novel biomarker for familial hypercholesterolaemia

Baragetti A., Alieva A., Grigore L. et al.

European Heart Journal, 2025
Mosaic loss of Y chromosome and mortality after coronary angiography

Weyrich M., Zewinger S., Sarakpi T. et al.